Literature DB >> 6334572

Prevalence of viral hepatitis markers in the population of Portugal.

H Lecour, A T Ribeiro, I Amaral, M A Rodrigues.   

Abstract

The prevalence of viral hepatitis markers in apparently healthy individuals of both sexes, born and living in both urban and rural areas of all the Portuguese provinces, was studied by radioimmunoassay.The anti-HAV prevalence was determined in 1770 individuals, 1-84 years old, divided into 8 age groups. The HBsAg prevalence was determined in 1440 individuals, 15-84 years old, divided into 5 age groups, while the anti-HBs prevalence was determined in 1980 individuals, 1-84 years old, divided into 8 age groups. The data were standardized for the Portuguese population.The anti-HAV results were similar for both sexes and showed a general prevalence of 84.9%. No significant difference in the prevalences between urban and rural areas was found. Age-group prevalences of anti-HAV were: 1-4 years, 23.9%; 5-9 years, 61.3%; 10-14 years, 76.4%; 15-19 years, 93.4%; and over 30 years, 99%.The HBsAg results showed a general prevalence of 1.25% for persons over 15 years old (2.04% for males and 0.78% for females). The anti-HBs results were similar for both sexes and showed a general prevalence of 24.3%. The northern provinces tended to have a higher anti-HBs prevalence than the southern ones, except for Lisbon province which had the highest figure. Age-group prevalences of anti-HBs were: 1-4 years, 7.6%; 5-9 years, 12.6%; 10-14 years, 8.7%; 15-19 years, 23.5%; 20-29 years, 28.4%; and over 30 years, between 30.0% and 34.3%.Only 5.3% of the anti-HAV-positive individuals, 11.2% of the HBsAg carriers, and 9.2% of the anti-HBs-positive individuals had a history of acute hepatitis.These results show that Portugal may be considered an endemic area for viral hepatitis infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334572      PMCID: PMC2536228     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

Review 1.  Hepatitis A virus infection: new insights from seroepidemiologic studies.

Authors:  J L Dienstag; W Szmuness; C E Stevens; R H Purcell
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

2.  The changed epidemiology of hepatitis A infection in Scandinavia.

Authors:  S Iwarson; G Frösner; A Lindholm; G Norkrans
Journal:  Scand J Infect Dis       Date:  1978

3.  Hepatitis B e antigen and infectivity of hepatitis B virus.

Authors:  T Shikata; T Karasawa; K Abe; T Uzawa; H Suzuki; T Oda; M Imai; M Mayumi; Y Moritsugu
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

Review 4.  Recent advances in the study of the epidemiology of hepatitis B.

Authors:  W Szmuness
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

5.  OMGE--Study on prevalence of hepatitis B surface antigen in different liver diseases.

Authors:  F Wewalka; S Hadziyannis; F X Pesendorfer; B Dragosics; W Base
Journal:  Scand J Gastroenterol Suppl       Date:  1979

6.  Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.

Authors:  O Sobĕslavský
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

7.  Epidemiologic characteristics of hepatitis A virus infections in Greece.

Authors:  G J Papaevangelou; K P Gourgouli-Fotiou; H G Vissoulis
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

8.  The three type of human viral hepatitis.

Authors:  A J Zuckerman
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

9.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

Authors:  G G Frösner; G Papaevangelou; R Bütler; S Iwarson; A Lindholm; A Couroucé-Pauty; H Haas; F Deinhardt
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

  9 in total
  5 in total

1.  Not all travellers need immunoglobulin for hepatitis A.

Authors:  J H Cossar; D Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

2.  Epidemiological aspects of acute viral hepatitis in Portugal.

Authors:  H Lecour; A Tomé-Ribeiro; I Amaral; M A Rodrigues
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

3.  Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012).

Authors:  Sara Pereira; Inês Linhares; António Ferreira Neves; Adelaide Almeida
Journal:  Viruses       Date:  2014-03-14       Impact factor: 5.048

4.  Conscience imperative of providing information and knowledge in hepatology: The Portuguese approach.

Authors:  Guilherme Macedo; Marco Silva
Journal:  World J Clin Cases       Date:  2017-01-16       Impact factor: 1.337

5.  Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score.

Authors:  Pedro Magalhães-Costa; Luís Lebre; Paula Peixe; Sofia Santos; Cristina Chagas
Journal:  GE Port J Gastroenterol       Date:  2016-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.